XML 52 R41.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Summary of Significant Accounting Policies - Additional Information (Details)
$ in Thousands
1 Months Ended 3 Months Ended 12 Months Ended
Aug. 26, 2024
May 31, 2023
USD ($)
Jun. 30, 2024
USD ($)
Jun. 30, 2023
USD ($)
Mar. 31, 2024
USD ($)
Nov. 01, 2021
USD ($)
Concentration Risk [Line Items]            
Restricted cash     $ 10,500   $ 8,400  
Decrease in escrow deposit   $ 6,000 (6,200)      
Proceeds from merger         309,700  
Proceeds from PIPE investment         250,000  
Cash and cash equivalents     $ 169,971 $ 314,351 $ 216,488  
Minimum | Subsequent Event            
Concentration Risk [Line Items]            
Reverse stock split 0.200          
Maximum | Subsequent Event            
Concentration Risk [Line Items]            
Reverse stock split 0.0333          
Lemonaid Health, Inc.            
Concentration Risk [Line Items]            
Escrow deposit           $ 13,000
Microarrays | Cost of Goods and Service, Product and Service Benchmark | Supplier Concentration Risk            
Concentration Risk [Line Items]            
% of Revenue     100.00% 100.00%    
K I T S | Cost of Goods and Service, Product and Service Benchmark | Supplier Concentration Risk            
Concentration Risk [Line Items]            
% of Revenue     100.00% 100.00%    
Laboratory Services | Cost of Goods and Service, Product and Service Benchmark | Supplier Concentration Risk            
Concentration Risk [Line Items]            
% of Revenue     100.00% 100.00%